肿瘤标志物联合检测在内蒙古地区宫颈癌诊断中的临床分析  

Clinical Research on the Combined Detection of Tumor Markers in the Diagnosis of Cervical Cancer in Inner Mongolia Area

作　　者：田丽丽[1] 闫全志[1] 吴金锁[1] 樊利和[1] 

机构地区：[1]内蒙古医科大学附属人民医院检验科,内蒙古呼和浩特010020

出　　处：《内蒙古医学杂志》2017年第3期293-294,共2页Inner Mongolia Medical Journal

基　　金：内蒙医科大学附属人民医院科研项目

摘　　要：目的探讨肿瘤标志物(TM)的检测在内蒙古地区宫颈癌诊断中的临床分析。方法选取2015年10月至2016年10月在我院接受治疗的内蒙古地区宫颈癌患者80例,宫颈上皮瘤样变(CIN)40例及健康体检者20例,比较SCC、CA-125、CA-153的表达水平变化及阳性率统计。结果宫颈癌组TM表达水平明显高于CIN组及对照组,P<0.05;在宫颈癌中的阳性率高于CIN组,P<0.05。结论 TM的联合检测在临床上有助于宫颈癌的早期诊断,对辅助治疗内蒙古地区CIN及宫颈癌具有重要的现实意义。Objective Investigate the clinical significance of tumor markers（TM）in the diagnosis of cervical cancer in Inner Mongolia area.Methods Selected 80 cases of cervical cancer,cervical intraepithelial neoplasia（CIN）in 40 cases and 20 cases of healthy check-up in the same period,the expression level of SCC,CA-125,CA-153 and the positive rate were compared.Results The expression level of TM in cervical cancer group was significantly higher than that in CIN group and control group,P〈0.05;the positive rate in cervical cancer was higher than that in CIN group,P〈0.05.Conclusion The combined detection of TM is helpful to the early diagnosis of cervical cancer,and has important practical significance for the adjuvant treatment of CIN and cervical cancer in Inner Mongolia area.

关 键 词：肿瘤标志物 宫颈癌 

分 类 号：R737.33[医药卫生—肿瘤]